Auritidibacter ignavus: an underestimated pathogen?

Auritidibacter ignavus is an emerging diagnosed microorganism associated with fulminant otitis, mastoiditis and recurrent otitis. Here we describe a clinical case in a little girl in La Gomera Island together with images of the bacteriological culture and whole genome sequencing.

Pneumonia due to case report and considerations.

Community acquired pneumonia is frequent in the elderly but a pathogen is identified in less than fifty per cent of the cases. It is rarely produced by , a Gram-negative oral commensal of many dogs and cats. We report the case of an elderly man with chronic obstructive respiratory disease who owned a dog and developed severe pneumonia due to

Effect of Concomitant Use of Proton Pump Inhibitors on Immunotherapy Clinical Response in Advanced Cancer Patients: Real-Life Setting.

The alteration of the gut microbiota mediated by proton pump inhibitor (PPI) drugs could be involved in the clinical response associated with immunotherapy [immunocheckpoint inhibitors (ICIs)] in cancer patients. Due to the current controversy in the scientific evidence, it has been proposed to evaluate the correlation between the concomitant use of PPIs and the effectiveness of immunotherapy in a real clinical practice setting. Single-center retrospective cohort study that included patients treated with anti-PD-1 or anti-CTLA4, including nivolumab, pembrolizumab, atezolizumab, or the combination ipilimumab-nivolumab in metastatic neoplastic disease.

[Not Available].

Objetivo: Proporcionar recomendaciones para la detección temprana de pacientes con alto riesgo de desarrollar cáncer de pulmón (CP) en el primer nivel de atención y su referencia oportuna. Material y métodos. Se realizó una búsqueda detallada de la evidencia científica disponible para responder las preguntas de investigación clínica y se utilizó el Panel Delphi modificado para lograr un consenso entre expertos.

First Census of Patients with Hereditary Angioedema in the Canary Islands.

Hereditary angioedema (HAE) is a rare genetic condition whose main symptoms are recurrent swelling in the skin, mucosa, and internal organs. Recent studies suggested that the regulation of the inflammatory response and the complement cascade are two of the pathways significantly enriched in the Canary Islands, Spain. Here, we describe the first HAE patient series in this region.

Survey on the use of zinc sulfate in parenteral nutrition in spanish hospitals.

Objective: In certain situations parenteral nutrition subsidiary patients may  have an increase in zinc demand (Zn). The objective of the study was to know  the scope of the use of Zn sulfate in patients with parenteral nutrition in Spanish hospitals.

Method: A survey was designed focusing on the incorporation of Zn sulfate into  parenteral nutrition, under real practice conditions, in the adult and pediatric  population.

[Regional protocol for adjusting the therapeutic intensity. Southern Metropolitan Area of Barcelona].

The identification of patients with advanced and complex chronic diseases, and the fragmentation of care towards the end of life, requires the drawing up a long-term therapeutic plan. This should take into account the values and preferences of the patients, as well as the vital and functional prognosis. Having an adjustment tool for determining the diagnostic and therapeutic effort is helpful in the continuity of care, as well as in decision-making in the transitions and dynamic changes of patients as they approach the end of life process.

STEMI Interventions: The European Perspective and Stent for Life Initiative.

The Stent for Life Initiative was launched by the European Association of Percutaneous Cardiovascular Interventions (a registered branch of the ESC) and EuroPCR. The purpose of the initiative is to support the implementation of European Society of Cardiology guidelines on management of acute myocardial infarction, help identify barriers to implementation of guidelines, and define actions to ensure that the majority of ST-segment elevation myocardial infarction (STEMI) patients in Europe have access to primary percutaneous coronary intervention. The key objectives are to define the countries with an unmet medical need in the optimal treatment of STEMI and implement an action program to increase patient access to primary percutaneous coronary intervention.